Stabilization of aerosolized IFN-γ by liposomes

被引:20
作者
Kanaoka, E [1 ]
Nagata, S [1 ]
Hirano, K [1 ]
机构
[1] Shionogi & Co Ltd, Formulat Res & Dev Labs, Fukushima Ku, Osaka 5530002, Japan
关键词
stabilization; recombinant interferon-gamma (IFN-gamma); liposome; aerosol; nebulization;
D O I
10.1016/S0378-5173(99)00218-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aerosolized IFN-gamma is very unstable. We have improved the stability of IFN-gamma in the jet nebulizer by adding small liposomes. Aerosolized IFN-gamma was recovered in PBS solution by bubbling and its concentration was determined. After nebulization for 30 min, aerosolized IFN-gamma, was detected only 0.4 +/- 0.2% of the initial amount in the PBS solution and 3.1 +/- 0.7% in the reservoir. On the other hand, the addition of small liposomes (HSPC/DSPG = 10/1 (molar ratio), 45 +/- 24 nm) in the nebulizer increased the stability of IFN-gamma, 27.2 +/- 4.7% of the initial amount in the PBS solution and 25.7 +/- 12.6% in the reservoir. The present study also examined the effects of composition and concentration of liposomes on the stabilization of aerosolized IFN-gamma. Liposome prepared from distearoyl phosphatidylcholine (DSPC) or hydrogenated soy phosphatidylcholine (HSPC) was very effective for stabilization of aerosolized IFN-gamma (DSPC/DPPG = 10/1, HSPC/DSPG = 10/1). HSPC/DSPG liposome was efficient at the concentration higher than 12.5 mu mols/ml for the stabilization of 5 x 10(5) JRU/ml of IFN-gamma. In considering the mechanism of this stabilization, the results of gel filtration chromatography suggest that IFN-gamma is inactivated by polymerization or aggregation in nebulization, while the inactivation is suppressed by liposomes due to their adsorption to IFN-gamma. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 23 条
[1]  
ADJEI AL, 1997, LUNG BIOL HLTH DIS, V107
[2]   Pulmonary pharmacokinetics of cyclosporin A liposomes [J].
Arppe, J ;
Vidgren, M ;
Waldrep, JC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 161 (02) :205-214
[3]   SUSTAINED DELIVERY OF DETIRELIX AFTER PULMONARY ADMINISTRATION OF LIPOSOMAL FORMULATIONS [J].
BENNETT, DB ;
TYSON, E ;
MAH, S ;
DEGROOT, JS ;
HEGDE, SG ;
TERAO, S ;
TEITELBAUM, Z .
JOURNAL OF CONTROLLED RELEASE, 1994, 32 (01) :27-35
[4]   REAGENTS WHICH INHIBIT DISULFIDE BOND FORMATION STABILIZE HUMAN FIBROBLAST INTERFERON [J].
CARTWRIGHT, T ;
SENUSSI, O ;
GRADY, MD .
JOURNAL OF GENERAL VIROLOGY, 1977, 36 (AUG) :326-327
[5]   Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol [J].
Condos, R ;
Rom, WN ;
Schluger, NW .
LANCET, 1997, 349 (9064) :1513-1515
[6]   SELECTIVE INDUCTION OF PROTECTION AGAINST INFLUENZA-VIRUS INFECTION IN MICE BY A LIPID-PEPTIDE CONJUGATE DELIVERED IN LIPOSOMES [J].
FRIEDE, M ;
MULLER, S ;
BRIAND, JP ;
PLAUE, S ;
FERNANDES, I ;
FRISCH, B ;
SCHUBER, F ;
VANREGENMORTEL, MHV .
VACCINE, 1994, 12 (09) :791-797
[7]   PREPARATION AND CHARACTERIZATION OF INTERFERON-GAMMA-CONTAINING LIPOSOMES [J].
GOLDBACH, P ;
DUMONT, S ;
KESSLER, R ;
POINDRON, P ;
STAMM, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 123 (01) :33-39
[8]  
GOLDELIY VI, 1996, J MOL STRUCT, V383, P117
[9]  
Herrmann J, 1995, EUR J PHARM BIOPHARM, V41, P361
[10]  
HIRANO K, 1996, PROG DRUG DELIV SYST, V5, P113